Home
About us
Strategy and Business Model
Board of Directors
Management Team
Medical Advisors
Business Development
History
Career
Projects
SpagoPix
Tumorad
Nanomedicine
The EPR-effect
Companion Diagnostics
Publications
Investors
The Share
Owners
General Meetings
Calendar
Financial Reports
Auditor
Presentations
Analyst Coverage
Media
Corporate Profile
Press Releases
News
Image Bank
Contact
- Select -
Home
About us
- Strategy and Business Model
- Board of Directors
- Management Team
- Medical Advisors
- Business Development
- History
- Career
Projects
- SpagoPix
- Tumorad
Nanomedicine
- The EPR-effect
- Companion Diagnostics
Publications
Investors
- The Share
- Owners
- General Meetings
- Calendar
- Financial Reports
- Auditor
- Presentations
- Analyst Coverage
Media
- Corporate Profile
- Press Releases
- News
- Image Bank
Contact
SHARE:
+/-:
-0.08
SEK / Bid:
7.64
SEK / Ask:
7.78
SEK / Price:
7.82
SEK / High:
7.94
SEK / Low:
7.62
SEK / Quantity:
37 056
/ Turnover:
285 084
SEK / 2021-01-27 16:26 (CET)
Home
About us
Strategy and Business Model
Board of Directors
Management Team
Medical Advisors
Business Development
History
Career
Projects
SpagoPix
Tumorad
Nanomedicine
The EPR-effect
Companion Diagnostics
Publications
Investors
The Share
Owners
General Meetings
Calendar
Financial Reports
Auditor
Presentations
Analyst Coverage
Media
Corporate Profile
Press Releases
News
Image Bank
Contact
Financial Reports
2020
Interim Report Jan-Mar 2020 (Swedish)
Interim Report Apr-Jun 2020 (Swedish)
Interim Report Jul-Sep 2020 (Swedish)
2019
Annual Report 2019 (English)
Interim Report Jan-Mar 2019 (Swedish)
Interim Report Apr-Jun 2019 (Swedish)
Interim Report Jul-Sep 2019 (Swedish)
Year End Report Jan-Dec 2019 (Swedish)
2018
Annual Report 2018 (Swedish)
Interim Report Jan-Mar 2018 (Swedish)
Interim Report Jan-Jun 2018 (Swedish)
Interim Report Jan-Sep 2018 (Swedish)
Year End Report Jan-Dec 2018 (Swedish)
2017
Annual Report 2017 (Swedish)
Interim Report Jan-Mar 2017 (Swedish)
Interim Report Jan-Jun 2017 (Swedish)
Interim Report Jan-Sep 2017 (Swedish)
Year End Report Jan-Dec 2017 (Swedish)
2016
Annual Report 2016 (Swedish)
Interim Report Jan-Mar 2016 (Swedish)
Interim Report Jan-Jun 2016 (Swedish)
Interim Report Jan-Sep 2016 (Swedish)
Year End Report Jan-Dec 2016 (Swedish)
2015
Annual Report 2015 (Swedish)
Interim Report Jan-Mar 2015 (Swedish)
Interim Report Jan-Jun 2015 (Swedish)
Interim Report Jan-Sep 2015 (Swedish)
Year End Report Jan-Dec 2015 (Swedish)
2014
Annual Report 2014 (Swedish)
Interim Report Jan-Mar 2014 (Swedish)
Interim Report Jan-Jun 2014 (Swedish)
Interim Report Jan-Sep 2014 (Swedish)
Year End Report Jan-Dec 2014 (Swedish)
2013
Interim Report
Jan-Mar 2013 (Swedish)
Interim Report Jan-Jun 2013 (Swedish)
Interim Report Jan-Sep 2013 (Swedish)
Year End Report Jan-Dec 2013 (Swedish)
2012
Year End Report Jan-Dec 2012 (Swedish)
Home
About us
Strategy and Business Model
Board of Directors
Management Team
Medical Advisors
Business Development
History
Career
Back
Projects
SpagoPix
Tumorad
Back
Nanomedicine
The EPR-effect
Companion Diagnostics
Back
Publications
Investors
The Share
Owners
General Meetings
Calendar
Financial Reports
Auditor
Presentations
Analyst Coverage
Back
Media
Corporate Profile
Press Releases
News
Image Bank
Back
Contact